Want to help those with a substance use disorder?

If you are a non-smoker, you could qualify for a research study at NIDA.

We are seeking study participants who are 18-60 years of age and do not smoke or vape nicotine.

Study Name

Orexin's Role in the Neurobiology of Substance Use Disorder
Study# 001066-DA
Study Nickname: Orexin (Non-smokers)

Purpose

This study is being done to examine how methylphenidate (marketed as Ritalin^®) and suvorexant (marketed as Belsomra^®) can influence reward and cognition in healthy populations.

Length of Study

5-6 outpatient visits over 1-2 months.

Study Activities

Questionnaires, MRI scans, blood draws, and taking 2 medications (suvorexant and methylphenidate) or a placebo for several days before scans.

Compensation

Up to $1,315.

Local Travel

Will be provided (via Uber Health) or reimbursed.

Complete the online pre-screener to see if you qualify for one of our studies.

Pre-screener

Have further questions or prefer to speak to a staff member directly?

Call now for a confidential screening:

800-535-8254

If right now isn't convenient:

Contact Form

More information about this study is available here.